Videolaparoscopic nephrectomy in a 69 years old patient with renal cell carcinoma
October 9, 2022
September 9, 2023
Renal cell carcinoma represents 2-3% of all adult neoplasms and it is the most frequent and lethal of all urological neoplasms. The treatment of choice in patients with localized disease is radical nephrectomy. Next, we present the case of a 69 yea
1.
RIVAS CASTAÑEDA P, González Reynoso G. Videolaparoscopic nephrectomy in a 69 years old patient with renal cell carcinoma. Rev. méd. (Col. Méd. Cir. Guatem.) [Internet]. 2023 Sep. 9 [cited 2024 Dec. 22];163(1). Available from: https://stage.revistamedicagt.org/index.php/RevMedGuatemala/article/view/617
Downloads
Download data is not yet available.
El carcinoma de células claras representa el 2-3% de todas las neoplasias en adultos y
es la neoplasia más común y letal de las neoplasias urológicas.
Copyright (c) 2023 PAULA RIVAS CASTAÑEDA, Dr. Gustavo González Reynoso
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
Copyright notice |
Authors will retain their copyright and assign to the journal the right of first publication of their work, which will be simultaneously subject to a Creative Commons Attribution-Noncommercial-ShareAlike 4.0 International license (CC BY-NC-SA 4.0) that allows third parties to share the work as long as its author and its first publication in this magazine are indicated. | |
Authors may adopt other non-exclusive license agreements for the distribution of the version of the published work (eg: deposit it in an institutional repository or publish it in a monographic volume) provided that the initial publication in this journal is indicated. | |
Authors are allowed and recommended to disseminate their work through the internet (eg, in institutional telematic files or on their website) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The effect of open access). |
About the Creative Commons license |
Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
You are free to: |
Share — copy and redistribute the material in any medium or format. | |
Adapt — remix, transform, and build upon the material. | |
The licensor cannot revoke these freedoms as long as you follow the license terms. |
Under the following terms: |
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. | |
NonCommercial — You may not use the material for commercial purposes. | |
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. |
|
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. |